Jim L. Allen is Director at BioCardia, Inc. (BCDA). They have made 1 open-market trade across 1 company since 2020, most recently 2024-09-03.
CIK 0001789590
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $300K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCDA | 109,661 | $101K |
Shares reported on the most recent Form 4, priced at the 2024-09-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCDA | BUY | 2020-06-19 | 2020-06-23 | $2.10 | $300K | -16.1% | -3.6% | -6.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.